Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
While Health Canada says it is "aware" of the U.S. decision to withdraw the emergency use of Evusheld, a drug by AstraZeneca used to help prevent COVID-19 infection--- the agency is maintaining its approval, citing the differences in variant circulation between Canada and the U.S.
The U.S. Food and Drug Administration (FDA) announced on Jan. 26 that its emergency use authorization of the drug was pulled due to its inefficacy in treating “certain” COVID-19 variants.
The FDA stated in a release on its website that as the XBB.1.5. variant, nicknamed “Kraken”, is making up the majority of cases in the country, the use of Evusheld is “not expected to provide protection” and therefore not worth exposing the public to possible side effects of the drug, like allergic reactions.
In an email to CTVNews.ca, Health Canada said the U.S. Food and Drug Administration pulled the drug as the main variant of concern in the U.S. is XBB.1.5.
"Dominant variants in the [U.S.] may be different from those circulating in Canada," the federal agency said in an email. "The most recent epidemiological data in Canada (as of January 1, 2023) indicate that BA.5 (Omicron) subvariants continue to account for more than 89 per cent of reported cases."
On Jan. 6 the FDA said in press release that certain variants are not neutralized by Evusheld and cautioned people who are exposed to XBB.1.5. On Jan. 26, the FDA then updated its website by saying it would be limiting the use of Evusheld.
"Evusheld is not currently authorized for use in the U.S. until further notice by the Agency," the FDA website states.
On Jan. 17, Health Canada issued a "risk communication" on Evusheld, explaining how it may not be effective against certain Omicron subvariants when used as a preventative measure or treatment for COVID-19.
"Decisions regarding the use of EVUSHELD should take into consideration what is known about the characteristics of the circulating COVID-19 variants, including geographical prevalence and individual exposure," Health Canada said in an email.
Health Canada says Evusheld does neutralize against Omicron subvariant BA.2, which according to the agency, is the dominant variant in many communities in Canada.
The drug was introduced for prevention measures specifically for people who have weaker immune systems and are unlikely to be protected by a COVID-19 vaccine. It can only be given to people 12 years and older.
"EVUSHELD is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended," the agency's website reads.
Health Canada says no drug, including Evusheld, is a substitute for vaccination.
COVID-19 COVERAGE
CTVNews.ca Top Stories
Budget 2023 prioritizes pocketbook help and clean economy, deficit projected at $40.1B
In the 2023 federal budget, the government is unveiling continued deficit spending targeted at Canadians' pocketbooks, public health care and the clean economy.

Freeland's green economy spending aimed at competing with U.S. Inflation Reduction Act
Finance Minister Chrystia Freeland says clean energy and green technology spending may not have been the big-ticket items of the 2023 federal budget if it weren’t for the need to compete with infrastructure spending in the United States.
Federal government capping excise tax on alcohol after outcry
The increase in excise duties on all alcoholic products is being temporarily capped at two per cent starting next month instead of a planned 6.3 per cent increase.
opinion | The gun control debate in America has been silenced
In the wake of another deadly mass shooting in America, that saw children as young as nine years old shot and killed, the gun control debate is going nowhere, writes CTV News political analyst Eric Ham.
Was Stonehenge a giant calendar? New research suggests maybe not
Stonehenge's purpose has long been a mystery, with some researchers proposing that it may have been an ancient solar calendar. But now, new analysis suggests the calendar theory is unsubstantiated.
Kids would rather learn from smart robots than less-smart humans: new study
A new study published by Canadian researchers suggests that kindergarten-age children would rather be taught by a competent robot than an incompetent human.
‘Using waste material makes sense’: Mysterious artist Junko turns trash into giant sculptures
A mysterious, Montreal-based street artist named Junko is generating buzz in Metro Vancouver with futuristic, bug-like sculptures made from old car parts, scrap metal and tossed out shoes.
New research finds subtle brain changes in pre-symptomatic Alzheimer’s patients
A new peer-reviewed study from the Medical University of South Carolina report in Brain Connectivity has found individualized brain fingerprints which can help diagnose early Alzheimer's disease.
Hamilton family raising awareness about Strep A after sudden death of toddler
A Hamilton, Ont., family is hoping to raise awareness about Strep A after the tragic death of their two-year-old.